Logo image
Driving mitochondrial fission improves cognitive, but not motor deficits in a mouse model of Ataxia of Charlevoix-Saguenay
Preprint   Open access

Driving mitochondrial fission improves cognitive, but not motor deficits in a mouse model of Ataxia of Charlevoix-Saguenay

Chunling Chen, Ronald A Merrill, Chian Ju Jong and Stefan Strack
Research square
04/10/2024
DOI: 10.21203/rs.3.rs-4178088/v1
PMCID: PMC11042405
PMID: 38659734
url
https://doi.org/10.21203/rs.3.rs-4178088/v1View
Preprint (Author's original)This preprint has not been evaluated by subject experts through peer review. Preprints may undergo extensive changes and/or become peer-reviewed journal articles. Open Access

Abstract

Autosomal-recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is caused by loss-of-function mutation in the gene, which encodes sacsin, a putative HSP70-HSP90 co-chaperone. Previous studies with knock-out (KO) mice and patient-derived fibroblasts suggested that mutations inhibit the function of the mitochondrial fission enzyme dynamin-related protein 1 (Drp1). This in turn resulted in mitochondrial hyperfusion and dysfunction. We experimentally tested this hypothesis by genetically manipulating the mitochondrial fission/fusion equilibrium, creating double KO (DKO) mice that also lack positive (PP2A/Bβ2) and negative (PKA/AKAP1) regulators of Drp1. Neither promoting mitochondrial fusion ( β KO) nor fission ( KO) influenced progression of motor symptoms in KO mice. However, our studies identified profound learning and memory deficits in aged KO mice. Moreover, this cognitive impairment was rescued in a gene dose-dependent manner by deletion of the Drp1 inhibitor PKA/Akap1. Our results are inconsistent with mitochondrial dysfunction as a primary pathogenic mechanism in ARSACS. Instead, they imply that promoting mitochondrial fission may be beneficial at later stages of the disease when pathology extends to brain regions subserving learning and memory.

Details

Metrics

8 Record Views
Logo image